This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Attention Deficit Hyperactivity Disorder  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Although the stimulants used to treat ADHD have abuse liability, short-term controlled studies do not indicate new onset or recurrence of substance abuse in adults with ADHD who are treated with stimulants under close medical supervision. Nevertheless, it is prudent to avoid stimulants in an adult with active substance abuse because of concerns of misuse or diversion. Although no guidelines exist on the monitoring of stimulants in adults, in general we see patients in the office monthly until an appropriate dose level and tolerability of the stimulants are established. We monitor patients every 3 to 6 months thereafter. Between office visits, because stimulants are nonrefillable and require hard copies of the prescription, requests for refills are managed by telephone (or e-mail) and left for pickup or mailed to the patient’s home.

In our article, we commented on the diagnostic validity of self-report of ADHD symptoms and the usefulness . . . [Full Text of this Article]

Timothy E. Wilens, MD
twilens@partners.org

Stephen V. Faraone, PhD; Joseph Biederman, MD
Massachusetts General Hospital
Harvard Medical School

RELATED ARTICLES

Stimulants and Attention-Deficit/Hyperactivity Disorder
Marc Raphaelson
JAMA. 2004;292(18):2214.
EXTRACT | FULL TEXT  

Attention-Deficit/Hyperactivity Disorder in Adults
Timothy E. Wilens, Stephen V. Faraone, and Joseph Biederman
JAMA. 2004;292(5):619-623.
EXTRACT | FULL TEXT